Society of Hematologic Oncology

Free SOHO Membership: www.sohoonline.org

 

Harnessing the Immune System for Treating AML: Targeting CD33 and IL-3, Bispecifiic Antibodies, Mechanisms of Action, Checkpoint Inhibitors in Clinical Trials

0 views
October 16, 2019
Comments 0
Login to view comments. Click here to Login